PRGO Q4 2020 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.3B-2.5% YoY

Gross Profit

$469M36.4% margin

Operating Income

-$52M-4.0% margin

Net Income

-$175M-13.6% margin

EPS (Diluted)

$-1.29

QoQ Revenue Growth

+28.6%

Cash Flow

Operating Cash Flow

$110M

Free Cash Flow

$44M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$11.5B

Total Liabilities

$5.8B

Stockholders' Equity

$5.7B

Cash & Equivalents

$632M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.3B	-2.5%
Gross Profit	$469M	$481M	-2.4%
Operating Income	-$52M	-$7M	-656.5%
Net Income	-$175M	-$19M	-821.1%

Revenue Segments

Consumer Self-Care Americas

$701M54%

Consumer Self-Care International

$352M27%

RX Pharmaceuticals

$236M18%

Geographic Segments

UNITED STATES

$870M67%

Europe

$340M26%

Other Geographical Areas

$80M6%

IRELAND

$7M1%